Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE: 300573)

Market Cap	13.78B
Revenue (ttm)	1.67B
Net Income (ttm)	321.60M
Shares Out	174.42M
EPS (ttm)	1.83
PE Ratio	43.07
Forward PE	30.71
Dividend	2.64 (3.35%)
Ex-Dividend Date	May 22, 2024

Volume	2,879,833
Open	82.30
Previous Close	78.98
Day's Range	77.43 - 82.30
52-Week Range	77.43 - 214.36
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Shenyang Xingqi Pharmaceutical Co.,Ltd.

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products. It also engages in the technology development, technical consultation, investment, and eye hospital businesses, as well as production and wholesale of pharmaceuticals. The company was founded in 1977 and is headquartered in Shenyang,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 1,995
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2023, Shenyang Xingqi Pharmaceutical Co.,Ltd.'s revenue was 1.47 billion, an increase of 17.42% compared to the previous year's 1.25 billion. Earnings were 240.04 million, an increase of 13.39%.